ITGR Stock Analysis: Buy, Sell, or Hold?
ITGR - Integer Holdings Corporation
$121.21
20.35 (20.18%)
▲
5d:
+22.91%
30d:
+28.17%
90d:
+36.94%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
3d
Get Alerted When ITGR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ITGR is 19.3% above its trading range ($101.63). Market expects 11.5% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ITGR is 19.3% above its trading range ($101.63). Market expects 11.5% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$128.32
Based on 8.1% avg growth
INTRINSIC VALUE TODAY
$79.68
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ITGR is currently trading at $121.21, which is considered extended relative to its 30-day fair value range of $90.20 to $101.63. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.8) compared to its historical average (12.8). At these levels, the market is pricing in 11.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ITGR is in a uptrend. The price is approaching resistance at $123.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 20.2% recently.
Market Sentiment: ITGR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $101.20. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ITGR is in a uptrend. The price is approaching resistance at $123.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 20.2% recently.
Market Sentiment: ITGR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $101.20. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$90.20 -
$101.63
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.7%
Protect Your Profits
ITGR is technically overbought (RSI 83). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+19.3% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+20.2%)
- BEARISH: Trading 16.5% above Wall St target ($101.20)
- NEUTRAL: Trading at premium valuation - market expects 11.5% growth which is achievable
- WARNING: Recommendation downgraded due to 19.3% overvaluation
Trading Range Analysis
30-Day Trading Range
$90.20 -
$101.63
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$94.91
Resistance Level
$123.50
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.78
Wall Street Target
$101.20
(-16.5%)
Revenue Growth (YoY)
0.5%
Earnings Growth (YoY)
52.9%
Profit Margin
7.6%
Valuation Premium vs History
+11.5% premium
PE vs Historical
17.8 vs 12.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.5%
(market-implied from PE analysis)
1-Year Target
$135.15
(+12%)
2-Year Target
$150.69
(+24%)
3-Year Target
$168.02
(+39%)
3-Yr Target (if PE normalizes)
(PE: 18→13)
PE COMPRESSION
$120.99
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 12.1%)
$199.01
(+64%)
Base:
(SPY PE: 17.8, Growth: 12.1%)
$170.64
(+41%)
Bear:
(PE: 12.8, Growth: 12.1%)
$122.88
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 25.03 | Current EPS (TTM): $4.03
Bull Case
$187.73
(+55%)
Analyst growth 69.2%, PE expands to 27.5
Base Case
$170.66
(+41%)
Market implied 69.2%, PE stable at 25.0
Bear Case
$68.58
(-43%)
Severe decline -20.0%, PE contracts to 21.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 1:10 PM ET
Data refreshes hourly during market hours. Next update: 2:10 PM
Data refreshes hourly during market hours. Next update: 2:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ITGR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Tommy P Thomas
SELL
825 shares
2026-03-13
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
Advanced ITGR Option Strategies
Professional options setups generated by AI based on today's ITGR price and gamma walls.
